Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Natac Biotech
Getafe, Madrid, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Natac develops and commercializes plant-based extracts and functional ingredients. Key branded products include ENDOLIVE (olive triterpenes for cardiovascular and metabolic support) and POMOLIVE (olive triterpenes combined with apple polyphenols for metabolic syndrome management). Products have demonstrated benefits including reduced inflammation, improved glycemic control, decreased blood pressure, reduced platelet aggregation, weight loss support, and improved lipid profiles.[1]
- Therapeutic areas
- EndocrinologyCardiovascularImmunologyMetabolic Disorders
- Modalities
- Plant extractFunctional ingredient
- Industry
- Food & Nutrition
02
Partnerships
Caleco Pharma Corp (exclusive license agreement for five plant extract compounds in North and South America, 2010)[2]
Beyond the preview
Go deeper on Natac Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Natac Biotech.